US 7256256
CDK4 binding peptide
granted A61KA61K38/10
Quick answer
US patent 7256256 (CDK4 binding peptide) held by UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Grant date
- Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/10